Pre-Session Views

In today's Pre-Session Views: Strategy| Market intelligence confirms Jirian contribution to PHDC value is minimalMacro| May 2025 inflation to hover around 15% on base effectCSAG vs ALCN| Post calling management of both firms, we continue to favor CSAG over ALCNRMDA| Strong FY25 ahead for RMDA, with growth momentum, molecule acquisition, and benefit from rate cutsTMGH conference call| Potential subsidiary listing on other markets could unlock valueEGAL| Dividend powerhouse with structura...